A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
The five-year trial saw patients who received a single injection of Lumevoq sustaining clinical recovery in a rare condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback